Cargando…
The DOTA macrocyclic cavity in metallic radiopharmaceuticals: Mythology or reality?
BACKGROUND: The hypothetical concept of ‘macrocyclic cavity’ is largely employed as useful model to interpret the affinity of metal ions for the macrocyclic chelating ligand 2,2′,2′′,2′′′-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetic acid (H(4)DOTA). It Is hypothesized that a close ma...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400501/ https://www.ncbi.nlm.nih.gov/pubmed/37535275 http://dx.doi.org/10.1186/s41181-023-00202-6 |
_version_ | 1785084460375474176 |
---|---|
author | Duatti, Adriano |
author_facet | Duatti, Adriano |
author_sort | Duatti, Adriano |
collection | PubMed |
description | BACKGROUND: The hypothetical concept of ‘macrocyclic cavity’ is largely employed as useful model to interpret the affinity of metal ions for the macrocyclic chelating ligand 2,2′,2′′,2′′′-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetic acid (H(4)DOTA). It Is hypothesized that a close matching between the size of the macrocyclic cavity and that of the metallic ion is a key parameter to ensure the high-yield formation of stable coordination metal-DOTA complex. This approach has become popular in the design of radiopharmaceuticals containing radiometals and H(4)DOTA as chelating group. RESULTS: Based on X-ray structural data of metallic complexes formed by the ligand H(4)DOTA upon coordination with a variety of metals, an elementary argument based on Euclidean geometry is presented here that questions the existence of the hypothetical ‘macrocyclic cavity’ within the chelator macrocycle. The geometrical analysis was applied to the complex formed by a Ga(3+) ion coordinated to H(4)DOTA as model compound. CONCLUSIONS: Application of Euclidean geometry to calculate bond angles in the coordination complex of the ligand H(4)DOTA with the Ga(+3) ion, supposed to incorporate a hypothetical ‘macrocyclic cavity’, revealed that this conceptual entity has no physical reality and, therefore, cannot be considered a meaningful description of a stable structural arrangement for metallic radiopharmaceuticals. |
format | Online Article Text |
id | pubmed-10400501 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-104005012023-08-05 The DOTA macrocyclic cavity in metallic radiopharmaceuticals: Mythology or reality? Duatti, Adriano EJNMMI Radiopharm Chem Research Article BACKGROUND: The hypothetical concept of ‘macrocyclic cavity’ is largely employed as useful model to interpret the affinity of metal ions for the macrocyclic chelating ligand 2,2′,2′′,2′′′-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetic acid (H(4)DOTA). It Is hypothesized that a close matching between the size of the macrocyclic cavity and that of the metallic ion is a key parameter to ensure the high-yield formation of stable coordination metal-DOTA complex. This approach has become popular in the design of radiopharmaceuticals containing radiometals and H(4)DOTA as chelating group. RESULTS: Based on X-ray structural data of metallic complexes formed by the ligand H(4)DOTA upon coordination with a variety of metals, an elementary argument based on Euclidean geometry is presented here that questions the existence of the hypothetical ‘macrocyclic cavity’ within the chelator macrocycle. The geometrical analysis was applied to the complex formed by a Ga(3+) ion coordinated to H(4)DOTA as model compound. CONCLUSIONS: Application of Euclidean geometry to calculate bond angles in the coordination complex of the ligand H(4)DOTA with the Ga(+3) ion, supposed to incorporate a hypothetical ‘macrocyclic cavity’, revealed that this conceptual entity has no physical reality and, therefore, cannot be considered a meaningful description of a stable structural arrangement for metallic radiopharmaceuticals. Springer International Publishing 2023-08-03 /pmc/articles/PMC10400501/ /pubmed/37535275 http://dx.doi.org/10.1186/s41181-023-00202-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article Duatti, Adriano The DOTA macrocyclic cavity in metallic radiopharmaceuticals: Mythology or reality? |
title | The DOTA macrocyclic cavity in metallic radiopharmaceuticals: Mythology or reality? |
title_full | The DOTA macrocyclic cavity in metallic radiopharmaceuticals: Mythology or reality? |
title_fullStr | The DOTA macrocyclic cavity in metallic radiopharmaceuticals: Mythology or reality? |
title_full_unstemmed | The DOTA macrocyclic cavity in metallic radiopharmaceuticals: Mythology or reality? |
title_short | The DOTA macrocyclic cavity in metallic radiopharmaceuticals: Mythology or reality? |
title_sort | dota macrocyclic cavity in metallic radiopharmaceuticals: mythology or reality? |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400501/ https://www.ncbi.nlm.nih.gov/pubmed/37535275 http://dx.doi.org/10.1186/s41181-023-00202-6 |
work_keys_str_mv | AT duattiadriano thedotamacrocycliccavityinmetallicradiopharmaceuticalsmythologyorreality AT duattiadriano dotamacrocycliccavityinmetallicradiopharmaceuticalsmythologyorreality |